| Pharmaceutical active ingredients: |
| AcetaminophenNimesulide |
| Available forms, composition and doses of Nimvista Plus: |
| Suspension; Oral; Acetaminophen 125 mg; Nimesulide 50 mg / 5 mlTablets; Oral; Acetaminophen; Nimesulide |
| Nimvista Plus medical category: |
| Human:Analgesics (non-opioid) and antipyreticsNonsteroidal anti-inflammatory drugs (NSAIDs) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M01AX17 - NimesulideN02BE01 - Paracetamol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| CadilaZydus Cadila |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nimustar-P | Acetaminophen; Nimesulide | Invision Medi Sciences |
| Nimusym-Plus | Acetaminophen; Nimesulide | Symbiosis |
| Nimutal-Plus | Acetaminophen; Nimesulide | Symbiosis; Coastal Healthcare |
| Nimvar-Plus | Acetaminophen; Nimesulide | ATOZ Pharmaceuticals |
| Nimven Plus | Acetaminophen; Nimesulide | Vensat Bio |
| Nisba Plus | Acetaminophen; Nimesulide | Osmed Formulations |
| Nizapas-P | Acetaminophen; Nimesulide | Daniel Pasteur |
| NMD-Plus | Acetaminophen; Nimesulide | Candor Biotech; Aileron Life Sciences |
| Nobel Plus | Acetaminophen; Nimesulide | Mankind Pharma |
| Nodard Plus | Acetaminophen; Nimesulide | Cipla |